Abbott

YTD

ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

CEO

Robert B. Ford

CEORobert B. Ford

Employees

115,000

Employees115,000

Headquarters

Abbott Park, Illinois

HeadquartersAbbott Park, Illinois

Founded

1888

Founded1888

Employees

115,000

Employees115,000

ABT Key Statistics

Market cap

176.02B

Market cap176.02B

Price-Earnings ratio

27.08

Price-Earnings ratio27.08

Dividend yield

2.38%

Dividend yield2.38%

Average volume

9.62M

Average volume9.62M

High today

$102.18

High today$102.18

Low today

$100.25

Low today$100.25

Open price

$100.67

Open price$100.67

Volume

11.69M

Volume11.69M

52 Week high

$139.06

52 Week high$139.06

52 Week low

$99.05

52 Week low$99.05

Stock Snapshot

As of today, Abbott(ABT) shares are valued at $100.76. The company's market cap stands at 176.02B, with a P/E ratio of 27.08 and a dividend yield of 2.4%.

On 2026-04-14, Abbott(ABT) stock moved within a range of $100.25 to $102.18. With shares now at $100.76, the stock is trading +0.5% above its intraday low and -1.4% below the session's peak.

Trading volume for Abbott(ABT) stock has reached 11.69M, versus its average volume of 9.62M.

The stock's 52-week range extends from a low of $99.05 to a high of $139.06.

ABT News

Simply Wall St 3h

Abbott’s Exact Sciences Deal Reshapes Diagnostics Value Story For Investors

Abbott Laboratories agreed to acquire Exact Sciences for $21b, marking the largest healthcare and diagnostic deal in two years. The transaction expands Abbott’...

Benzinga 17h

Top Wall Street Forecasters Revamp Abbott Expectations Ahead Of Q1 Earnings

Abbott Laboratories (NYSE:ABT) will release earnings for its first quarter before the opening bell on Thursday, April 16. Analysts expect the Abbott Park, Illi...

TipRanks 5d

Abbott Laboratories: Solid Q1 Setup and Resilient MedTech/Diagnostics Support Path to 2026 Targets Amid Manageable Geopolitical Headwinds

Analyst Josh Jennings from TD Cowen reiterated a Buy rating on Abbott Laboratories and keeping the price target at $137.00. Easter Sale - 70% Off TipRanks Unloc...

Analyst ratings

75%

of 32 ratings

Buy

75%

Hold

25%

Sell

More ABT News

Simply Wall St 5d

How Abbott Baby Formula Verdict and Rising Litigation Risk May Reshape Abbott Laboratories' Investment Profile

In late March 2026, a Chicago jury ordered Abbott Laboratories to pay US$53 million in compensatory damages to families alleging the company failed to adequatel...

Simply Wall St 6d

Assessing Abbott Laboratories Valuation After Precision Oncology Integration With Flatiron Health

Abbott Laboratories (ABT) is back in focus after announcing that its Precision Oncology test portfolio will be integrated into Flatiron Health’s OncoEMR platfor...

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.